{"disease":{"id":"low-risk-acute-graft-versus-host-disease","name":"low risk acute graft versus host disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03846479","title":"Itacitinib for Low Risk GVHD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"John Levine","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}